Literature DB >> 7955143

End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes.

F Quaini1, E Cigola, C Lagrasta, G Saccani, E Quaini, C Rossi, G Olivetti, P Anversa.   

Abstract

Proliferating cell nuclear antigen (PCNA) is a late growth-regulated gene that is expressed at the G1-S boundary of the cell cycle and is required for DNA synthesis and cell proliferation. Since quantitative results suggest that myocyte hyperplasia occurs in the decompensated human heart, we postulated that induction of the PCNA gene may be present in the failing heart in humans. PCNA protein was detected in myocardial samples obtained from the left and right ventricles of patients with congestive heart failure. Endomyocardial biopsies collected from donor subjects were used as control tissue. The percentage of positively stained myocyte nuclei in the ventricles was established by using PCNA monoclonal antibody and the immunoperoxidase technique. The localization of PCNA in myocytes was confirmed by alpha-sarcomeric actin antibody staining. PCNA labeling was present in left ventricular myocytes of 29 of the 32 hearts examined. In the right ventricle, 24 of the 29 samples showed positive staining. In a subset of 25 patients, the percentage of PCNA-labeled myocyte nuclei was measured and found to constitute 49 +/- 22% of left ventricular myocytes. A similar analysis for the right ventricle, conducted in 21 patients, showed that 49 +/- 19% of the myocyte nuclei exhibited PCNA protein. In addition, mitotic figures in myocytes were documented. A quantitative analysis of this cellular process revealed that 11 myocyte nuclei per 1 million cells exhibited mitotic images in chronic heart failure. Immediately after myocardial infarction, two cells per million showed mitotic division, and this phenomenon was restricted to the region adjacent to the necrotic tissue. No PCNA labeling or nuclear mitotic images were detected in the ventricular myocardium of control subjects. Thus, the observation that diffuse PCNA labeling and myocyte mitotic division are present in hearts with end-stage failure strongly suggests that adult ventricular myocytes are not terminally differentiated cells and that myocyte cellular hyperplasia may constitute a growth reserve mechanism of the diseased heart.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7955143     DOI: 10.1161/01.res.75.6.1050

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  30 in total

1.  Thread-grain transition of mitochondrial reticulum as a step of mitoptosis and apoptosis.

Authors:  Vladimir P Skulachev; Lora E Bakeeva; Boris V Chernyak; Lidia V Domnina; Alexander A Minin; Olga Yu Pletjushkina; Valeria B Saprunova; Innokenty V Skulachev; Valeria G Tsyplenkova; Jury M Vasiliev; Lev S Yaguzhinsky; Dmitry B Zorov
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

2.  Heart regeneration: Past, present and future.

Authors:  Adriana Bastos Carvalho; Antonio Carlos Campos de Carvalho
Journal:  World J Cardiol       Date:  2010-05-26

3.  Telomere shortening is an in vivo marker of myocyte replication and aging.

Authors:  J Kajstura; B Pertoldi; A Leri; C A Beltrami; A Deptala; Z Darzynkiewicz; P Anversa
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 4.  Plasticity of mesenchymal stem cells--regenerative medicine for diseased hearts.

Authors:  Satoshi Gojo; Akihiro Umezawa
Journal:  Hum Cell       Date:  2003-03       Impact factor: 4.174

Review 5.  Stem cells in the heart: what's the buzz all about?--Part 1: preclinical considerations.

Authors:  Rachel Ruckdeschel Smith; Lucio Barile; Elisa Messina; Eduardo Marbán
Journal:  Heart Rhythm       Date:  2008-02-15       Impact factor: 6.343

Review 6.  Molecular advances in reporter genes: the need to witness the function of stem cells in failing heart in vivo.

Authors:  Silvia Agostini; Fabio A Recchia; Vincenzo Lionetti
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

7.  Skeletal myoblast transplantation for repair of myocardial necrosis.

Authors:  C E Murry; R W Wiseman; S M Schwartz; S D Hauschka
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

Review 8.  Exosome and its roles in cardiovascular diseases.

Authors:  Wang Zhao; Xi-Long Zheng; Shui-Ping Zhao
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

Review 9.  Contemporary perspective on endogenous myocardial regeneration.

Authors:  Dejan Milasinovic; Werner Mohl
Journal:  World J Stem Cells       Date:  2015-06-26       Impact factor: 5.326

10.  Cardiovascular biology: A boost for heart regeneration.

Authors:  Mark Mercola
Journal:  Nature       Date:  2012-12-05       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.